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RbThe Notch signaling pathway controls cell fate choices at multiple steps during cell lineage progression. To
produce the cell fate choice appropriate for a particular stage in the cell lineage, Notch signaling needs to
interpret the cell context information for each stage and convert it into the appropriate cell fate instruction.
The molecular basis for this temporal context-dependent Notch signaling output is poorly understood, and to
study this, we have engineered a mouse embryonic stem (ES) cell line, in which short pulses of activated
Notch can be produced at different stages of in vitro neural differentiation. Activation of Notch signaling for
6 h speciﬁcally at day 3 during neural induction in the ES cells led to signiﬁcantly enhanced cell proliferation,
accompanied by Notch-mediated activation of cyclin D1 expression. A reduction of cyclin-D1-expressing cells
in the developing CNS of Notch signaling-deﬁcient mouse embryos was also observed. Expression of a
dominant negative form of cyclin D1 in the ES cells abrogated the Notch-induced proliferative response, and,
conversely, a constitutively active form of cyclin D1 mimicked the effect of Notch on cell proliferation. In
conclusion, the data deﬁne a novel temporal context-dependent function of Notch and a critical role for cyclin
D1 in the Notch-induced proliferation in ES cells., KIIT Post Ofﬁce, Bhubaneswar,
l rights reserved.© 2010 Elsevier Inc. All rights reserved.Introduction
Cellular differentiation is orchestrated by a surprisingly small
number of signaling mechanisms, and as a consequence of this
economic life style, signaling mechanisms are used reiteratively at
different time points in a given cell lineage to control cell fate
decisions (Hurlbut et al., 2007). To produce the appropriate signaling
output for each cell fate decision, the signaling pathway must sense
the cellular context at each given time point in order to provide the
correct stage-speciﬁc response, but little is known about how this is
accomplished during cell lineage progression.
The Notch signaling pathway is highly evolutionarily conserved
and is reiteratively used in cell fate decisions in many cell lineages.
Ligand activation of the membrane-bound Notch receptor ultimately
leads to a cleavage of the receptor, releasing the intracellular domain
of the Notch receptor (Notch ICD), which translocates to the cell
nucleus (Kopan and Ilagan, 2009). In the nucleus, Notch ICD interacts
with the DNA-binding protein CSL (also referred to as RBP-Jk) and
converts CSL from a transcriptional repressor to an activator, which
leads to activation of Notch downstream target genes, such as Hes andHey genes (Bray, 2006). Notch signaling plays a key role in many cell
lineages and is used at consecutive decision points, for example, in the
developing CNS (Mizutani et al., 2007). There is also evidence that
only a brief alteration of Notch signaling is sufﬁcient to execute a
particular fate decision. For example, in neural crest differentiation, a
short pulse of Notch was sufﬁcient to override BMP-mediated
neurogenesis at a step upstream of MASH1 (Morrison et al., 2000).
Conversely, blocking of Notch in the chick retina during Muller glia
de-differentiation to progenitor cells prevents regeneration, whereas
at a later stage, blocking of Notch leads to an increase in the number of
new neurons (Hayes et al., 2007).
The molecular mechanisms for how Notch signaling interprets the
cell context and how this modiﬁes the signaling outputs are not well
understood, and in this report, we have addressed this issue in mouse
embryonic stem (ES) cells. ES cells are pluripotent cells, which can be
in vitro differentiated into various lineages. The process of early
neural induction has been extensively studied in ES cells (Stavridis
and Smith, 2003). The early transitions are accompanied by a shift in
gene expression, where pluripotency-associated genes such as Oct4,
Nanog, and SSEA1 are downregulated, followed by a transient Sox1
activation and later expression of neural progenitor markers such as
nestin and BLBP. The molecular mechanisms controlling this transi-
tion are still poorly understood, but constitutive expression of Notch1
ICD in ES cells caused an accelerated entry into the neural lineage,
with an earlier onset of BLBP expression (Lowell et al., 2006). This
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and that the effects of charging the cells with a precise temporal
activation of Notch may provide insights into the temporal context-
dependent control of signaling output.
In this report, we have studied the effects of short pulses of Notch
signaling at different stages of early neural differentiation in ES cells.
The data identify a novel temporal-context-dependent Notch func-
tion, where Notch caused an increased level of proliferation when
activated speciﬁcally at day 3 in the early neural differentiation
process. This proliferative burst was accompanied by upregulation of
cyclin D1 by Notch, and cyclin D1was pivotal for executing the Notch-
induced proliferation, thus linking Notch directly to G1/S cell cycle
transition control in this process. The data provide new insights into a
role for Notch in ES cell proliferation and cell cycle control and unveil a
previously unrecognized temporal window during early stages of
neural differentiation.Materials and methods
Generation of the Notch1ΔETetOn cell line
A cDNA encoding mouse Notch1ΔE (a kind gift from Dr. Raphael
Kopan), a membrane-tethered form of mouse Notch1 that is a
constitutive substrate for the γ-secretase complex, was subcloned to a
vector encoding a multimerized glycine–serine linker and EGFP (a
kind gift from Dr. Shahragim Tajbakhsh), resulting in a cDNA cassette
encoding Notch1ΔE-EGFP. This cDNA was subsequently subcloned
into the plox vector to generate plox-Notch1ΔE-EGFP. AINV15 cells
were co-transfected with plox-Notch1ΔE-EGFP and CMV-Cre, and
following selection in G418, individual clones were picked and
analyzed for integration of the Notch1ΔE-EGFP cassette into the
loxP site immediately 3′ of a tetracycline-controlled promoter in the
HPRT locus by PCR. Two clones, #1 and #5, of the resulting cell line
(Notch1ΔETetOn) were expanded for further analysis. In the pAINV-15
cell line, the gene of interest is placed under control of a tetracycline-
responsive element in the HPRT locus, with the reverse tetracycline
transactivator (rtTA) constitutively expressed from the Rosa26 locus.
The plox vector and AINV15 cells were a kind gift from Drs. Michael
Kyba and George Daley (Kyba et al., 2002).Antibodies and pharmacological blockers
The primary antibodies used in this study were monoclonal anti-
cleaved Notch1 (Cell Signaling), polyclonal anti-cyclin D1 (Santa Cruz
Bio.), polyclonal anti-Oct4 (Santa Cruz Bio.), monoclonal anti-SOX2
(Abcam), monoclonal anti-SSEA-1 (Abcam), monoclonal anti-beta
actin (Sigma Aldrich), monoclonal anti-CD133-APC (eBiosciences), rat
anti-BrdU (Santa Cruz Bio.), polyclonal anti-Nestin (Almqvist et al.,
2002), monoclonal anti-Tuj1 (Covance), polyclonal anti-GFAP (Sigma
Aldrich), monoclonal anti-Histone-3 (Abcam), polyclonal anti-phos-
pho Rb (Cell Signaling), monoclonal anti-phospho p44/42 MAPK (Cell
Signaling), monoclonal anti-p21, monoclonal anti-p27, anti-Myc, and
anti-HA (Santa Cruz Bio). The secondary antibodies were anti-mouse
IgG-HRP and anti-rabbit IgG-HRP (DAKO). Wortmannin (PI3 kinase
blocker) and U0126 (MAP kinase blocker) were from Sigma Aldrich.Fig. 1. Generation and characterization of the Notch1ΔETetOn ES cell line. (A) Schematic rep
vector (Kyba et al., 2002). Brieﬂy, the AINV-15 vector contains the rtTA in the Rosa26 locus, a
placed under control of the tetracycline activation element. (B) Induction of Notch1ΔE prod
antibody speciﬁc for the new N-terminus in Notch1 ICD) demonstrates induction from
doxycycline. Loading control: reprobing with anti-β-actin (lower panel). (C) Loss of Not
doxycycline and blocking of activation by addition of DAPT in the presence of doxycycline. (E
as compared to simultaneous addition of docxycycline and DAPT (grey bar) or uninduced cell
markers (Oct4, Sox 2, and SSEA1) along with DAPI in the Notch1ΔETetOn cells cultured in ES
error bars indicate standard deviation: ***Signiﬁcant difference at pb0.001; **signiﬁcant diDNA constructs and transfection
Dominant negative cyclin D1 (T156A) was generously provided by
Prof. Charles J. Sherr and constitutively active cyclin D1 (T286A) was
procured from Addgene (Addgene plasmid 11182; submitted to
Addgene by Dr. Bruce Zetter). Constitutively active forms of the PI3
kinase (pCG-p110*) and Erk kinase (pCEP-MEK*) were a kind gift
from Dr. Jean-Francois Tanti. The reporter plasmids used here were
12XCSL-luciferase (Chapman et al., 2006) and the –1745 human
cyclin D1 promoter luciferase reporter was kindly provided by Prof.
Richard G. Pestell (Fu et al., 2005). The plox EGFP and pSalk-Cre were
generously provided by Prof. George Daley. Transfectionswere carried
out as described (Falk et al., 2007).Immunocytochemistry
Immunoﬂourescence staining was done as described previously
(Hansson et al., 2005). The immunoreactivity was visualized with
Openlab software or Zeiss LSM510 META confocal unit. Images were
cropped and assembled in Adobe Photoshop and arranged in Adobe
Illustrator.Western blot analysis
Western blots were produced as previously described (Laudon
et al., 2005). The blots were then scanned and quantiﬁed with ImageJ
software.FACS analysis
Cells in cultures were washed with PBS, before trypsinizing and
ﬁnally collected in ice-cold PBS supplemented with 4% FCS. These
were then stained with ﬂuorescent tagged antibodies against cell
surface antigens, for 30 min on ice. The same was done with the
isotype controls. The cells were then washed off the excess antibody
using PBS with 4% FCS. For analysis of cells with nuclear cyclin D1,
differential centrifugation was carried out to separate nuclear and
cytoplasmic fractions. The nuclear fractions were then stained with
cyclin D1 antibody prior to FACS analysis. The ﬂuorescently stained
cells were analyzed using FACS Aria.Luciferase reporter assay
Transfections of the luciferase reporter constructs were carried out
in 12-well tissue culture plates as have been described previously
(Laudon et al., 2005). Where indicated, a pulse of doxycycline for 6 h
was given to the cells 12 h post-transfection. Following this, cells were
lysed with lysis buffer (10 mM Tris, pH8, 1 mM EDTA, 150 mM NaCl,
and 0.65% Nonidet P-40) and monitored luminometrically for
luciferase activity after adding luciferin (BioTherma) and ATP
(BioTherma). The ﬁnal luciferase values were normalized with
reference to the β-galactosidase activity as an internal control. The
values are represented as relative luciferase units.resentation of the generation of the Notch1ΔETetOn cell line from the starting AINV-15
nd Notch1ΔE linked to EGFP was inserted by Cre recombination into the HPRT locus and
uction from the Notch1ΔETetOn cell line. Western blot of Notch1 ICD (recognized by an
1 to 5 μg / ml doxycycline, and undetectable levels of Notch1 ICD in the absence of
ch1 ICD 12 h after removal of doxycycline. (D) Activation of 12XCSL-luc by 2 μg/ml
) Activation of the Notch downstream genes Hey1 and Hey2 by doxycycline (black bar),
s (white bar). (F) Activation of EGFP expression by FACS. (G) Expression of pluripotency
medium. Bar graphs (D, E) show average activity from triplicates of each experiment,
fference at pb0.01. Scale bar: 40 μm.
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Total RNA extraction and quantitative PCR was performed as
previously described (Sahlgren et al., 2008). The real-time quantitativePCR was conducted on ABI 7500 (Applied Biosystems) as suggested by
the manufacturer. The primers were designed with PrimerExpress
program from Applied Biosystems. Primers were used for (mouse)
SOX1, Bcl 2, Cdc25A, E2F, Cyclin D1, Cyclin E, cMyc, Cyclin B1, Cyclin A,
157D. Das et al. / Developmental Biology 348 (2010) 153–166CDK4, CDK2, CDK1, GAPDH, and CDK6, and primer sequences are de-
scribed in Supplementary Fig. 1.
Mouse ES cell culture and neural differentiation
The mouse ES cells were grown at a density of 3–6×105 cells/
25 cm2 under feeder free conditions, in ES medium containing DMEM
(Invitrogen) supplemented with 10% knock-out serum (Invitrogen),
2% fetal calf serum, 0.1 mM nonessential amino acids, 1 mM sodium
pyruvate (Invitrogen) and 0.1 mM 2-mercaptoethanol (Sigma). For
neural differentiation, cells were grown in medium containing
DMEM-F12 and Neurobasal medium (Invitrogen 1:1) with N2
supplement and B27 as additives. Brieﬂy, 2×105 cells were plated
on gelatinized 6-well plates for neural differentiation.
Embryonic neural stem cell cultures
Rat embryonic neural stem cells (NSCs) were derived as previously
described (Gustafsson et al., 2005). Brieﬂy, rat cortical tissue from
embryonic day 15.5 was dissociated and 800×103 cells were plated
per 10-cm dish that ﬁrst had been coated with poly-L-ornithine and
ﬁbronectin (both from Sigma-Aldrich). NSCs were expanded in N2
media with 10 ng/ml of basic ﬁbroblastic growth factor (R&D
Systems) and subcultivated with mild dissociation in the presence
of HBSS, NaHCO3, and HEPES (from Invitrogen and Sigma-Aldrich).
Supplements were added daily, and medium was changed every
second day. Animals were treated in accordance with national and
institutional guidelines (Ethical permit no. N310/05).
Nucleofections
Nucleofections were performed according to the supplier's
recommendations (Rat NSC kit, program A-33, AMAXA-Lonza).
Three micrograms of plasmid cDNA and 3–4×106 cells were used
for each nucleofection. Cells were plated in N2medium supplemented
with 10 ng/ml FGF-2. Treatment with 2.5 nM DAPT (Calbiochem
#565770)was started the day after nucleofection. Cells were collected
for qRT-PCR analysis 48 h after nucleofection.
Karyotype
ES cells were trypsinized and resuspended in single cell suspen-
sion in hypotonic solution (0.56% KCl). Cells were incubated in the
hypotonic solution for 6 min before ﬁxing in Carnoy's ﬁxative (3:1;
methanol:acetic acid). The chromosome spreads were prepared after
washing in deionized water the preincubated slides in absolute
ethanol and concentrated hydrochloric acid (1:1) the day before. The
chromosomes were then stained with DAPI, visualized by using Zeiss
Axiovert 200 M microscopy, and captured with digital camera.
Recombinant Jagged1 ligand-induced activation of endogenous
Notch signaling
Endogenous Notch was activated using recombinant Jagged1
protein. Brieﬂy, cell culture plates were coated on speciﬁc days
initially with protein G, followed by recombinant human Fc (control)Fig. 2. Neural differentiation of the Notch1ΔETetOn cells after pulsed Notch activation. Immu
differentiation (days 1, 3, and 6) without doxycycline induction. (B) mRNA proﬁles for
representation of the scheme for pulsed activation of Notch during neural differentiation. A
analyzed at day 5 in neural differentiation. (D) Sox1 mRNA expression after no Notch activ
code indicates the day of doxycycline pulse as in panel C: red: pulse day 0, green: pulse day 1
Notch (white: constant doxycycline exposure for 4 days; analysis at the same day the cells ar
cells are harvested). (E) FACS analysis of CD133-positive cells on day 4 in neural induction a
stained with BrdU and nestin after a pulse of Notch induction. The bar graph represents the
sorting (right) of nestin expression in Notch1ΔETetOn cells with/without pulse of doxycycline
from triplicates of each experiment, error bars indicate standard deviation: **signiﬁcant difor Fc-Jagged1, as described in (Sahlgren et al., 2008). After washing off
excess recombinant Jagged1, the plates were precoated with 0.1%
gelatin prior to plating cells.
BrdU, propidium iodide staining, and caspase-3 staining
Cell proliferation was assayed using BrdU staining using APC BrdU
Flow kit (BD Pharmingen) following the manufacturer's instructions.
BrdU positivity was analyzed with FACSaria. Propidium iodide
staining was conducted on ethanol-ﬁxed cells resuspended in PI
solution (10 ml 0.1% tritonX/PBS, with 2 mg DNase-free RNase A and
10 mg/ml propidium iodide solution). In order to study apoptosis, PE-
conjugated polyclonal rabbit anti-active caspase-3 (BD pharmingen)
was used. Cells were initially formalin ﬁxed followed by permeabi-
lization with Tween-20 and ﬁnally stained with the antibody, before
analyzing with FACSaria. The cells with positive staining for activated
caspase-3 were documented.
Mice
All histological analysis was carried out at the animal facility at the
Department of Cell and Molecular Biology, Karolinska Institute, in
accordance with the ethical regulations for mouse work in Sweden.
Results
Engineering a mouse ES cell line for temporally controlled activation
of Notch
To be able to activate Notch with temporal precision in the ES cells,
we engineered an ES cell line with inducible expression of an
activated form of Notch, based on a previously described system for
inducible gene expression (Kyba et al., 2002). We introduced a gain-
of-function version of Notch1, Notch1 ΔE, linked to EGFP and tagged
with myc into the pAINV-15 cells (Fig. 1A), and the resulting cell line
is referred to as Notch1ΔETetOn. Notch1 ΔE was chosen as it represents
a membrane-tethered, ligand-independent form of Notch, which
upon cleavage by the γ-secretase complex generates a released
Notch1 ICD that represents an activated form of Notch. An advantage
of using the Notch1ΔE form, in contrast to expressing only the Notch1
ICD, is that activity can be blocked by the use of γ-secretase inhibitors,
and activity arising from expression from induction of Notch1 ΔE
expression can thus be tested for being an authentic Notch response
by pharmacological intervention by γ-secretase inhibitors.
We tested the efﬁcacy of Notch1ΔE induction in the Notch1ΔETetOn
cell line and the longevity of the produced protein, to determine the
duration of pulsed Notch activation. There was no detectable
production of Notch1 ICD (or Notch1 ΔE) in the absence of
doxycycline, a tetracycline homologue, but at doxycycline concentra-
tions ranging from 1 to 5 μg/ml, robust generation of Notch1 ICD was
observed (Fig. 1B), although concentrations beyond 4 μg/ml seemed
toxic (data not shown). Notch1 ICD levels were undetectable at 12 h
after removal of doxycycline from the medium (Fig. 1C). This
indicated that a good temporal control of Notch could be achieved
in our Notch1ΔETetOn cell line. The rapid disappearance of Notch ICD
after the withdrawal of doxycycline is most likely a consequence ofnocytochemistry for Oct4 and nestin in Notch1ΔETetOn cells at different stages of neural
Sox1, BLBP, and nestin during neural induction in N2B27 medium. (C) Schematic
6-h doxycycline pulse was given to the cells at day 0, 1, 2, 3, or 4 as indicated and cell
ation, constant Notch activation, or a Notch pulse (for the pulse experiments, the color
, yellow: pulse day 2, blue: pulse day 3, purple: pulse day 4, analysis at day 5). Constant
e harvested). No Notch (black: no doxycycline stimulation; analysis at the same day the
fter a day 3 pulse, as compared to untreated cells. (F) FACS plot showing Notch1ΔETetOn
quantiﬁcation of the data in the FACS plot. (G) Immunocytochemistry (left) and FACS
on day 3, analyzed on day 14 of neural differentiation. Bar graphs show average activity
ference at pb0.01; *signiﬁcant difference at pb0.05. Scale bars: A=20 μm, G=40 μm.
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containing the C-terminal PEST domain, which is the target for
ubiquitylation by cdc4 (Sel-10, Fbw7) followed by subsequent
proteasomal degradation (Dohda et al., 2007; Oberg et al., 2001).
To learn whether the production of Notch1 ICD was accompanied
by elevated Notch downstream signaling, we measured activation ofthe immediate downstream Notch reporter 12XCSL-luc. The 12XCSL-
luc reporter activity was rapidly increased by doxycycline, and this
increase was almost completely abrogated by the simultaneous
addition of the γ-secretase inhibitor DAPT (Fig. 1D). In keeping with
the elevated reporter activity, expression of the two Notch down-
stream genes Hey1 and Hey2 was observed (Fig. 1E). As an
Fig. 4. Pulsed Notch signaling alters G1/S cell cycle control and activates cyclin D1. (A, B) Analysis of cell cycle distribution following a day 3 pulse, constant doxycycline or no
doxycycline treatment. FACS plot (A) and the corresponding data in a bar graph (B). (C) Q-PCR analysis of cyclin D1 (left) and CDK6 (right) expression. (D) Q-PCR analysis of cyclin
D1+CDK6, cyclin A+CDK2, and cyclin B+CDK1 expression. (E) Western blot analysis of various cell cycle proteins, as indicated, in the absence of doxycycline (−) or after a
6-h pulse of doxycycline at day 3 (pulse). Analysis in panels A–E was performed at day 4 during neural differentiation, and the doxycycline pulse was given for 6 h on day 3, as
indicated (pulse: d3). Bar graphs show average activity from triplicates of each experiment, error bars indicate standard deviation: ***signiﬁcant difference at pb0.001.
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cells, we analyzed Notch induction by FACS, taking advantage of the
EGFP fusion to Notch1 ΔE. Doxycycline stimulation for 6 h yielded
approximately 70% EGFP-positive cells (Fig. 1F, Supplementary
Fig. 2A), and no EGFP positive cells were detected in the unstimulated
cells (Fig. 1F). To investigate whether the “negative” cell population,
i.e., the 30% of cells with EGFP levels under the cutoff level in the FACS
analysis, still expressed sufﬁcient levels of Notch signaling for
activation, we sorted out the negative population by FACS and
showed that expression of Hey1 and Hey2 was upregulated
(Supplementary Fig. 2B). Moreover, mRNA expression of Notch1 ICD
linked with GFP could be conﬁrmed by Q-PCR in the sorted “negative”
population (data not shown). This is in keeping with previousFig. 3. A pulse of Notch signaling at day 3 results in increased proliferation. (A) Analysis of ce
(B) Total cell number in cells pulsed at day 3 (arrow) or not treated with doxycycline for day
pulse, constant doxycycline treatment or in untreated cells. (D) Bcl-2-speciﬁc mRNA express
day 6 during neural differentiation. (E, F) Proportion of BrdU-positive cells after a day 3 pulse
doxycycline pulse and DAPT. The FACS plot is shown in panel E and the corresponding data i
day 3 pulse as compared to untreated cells. Immunocytochemistry (G) and the data in a bar g
signaling. (J) Bar graph showing the BrdU-positive population detected after plating the Notc
day 6 of neural differentiation. (K) BrdU-positive population of Notch1ΔETetOn cells tha
differentiation. Analysis in panels A–K was performed at day 6 of neural differentiation. Ba
standard deviation: ***signiﬁcant difference at pb0.001; **signiﬁcant difference at pb0.01;observations that only very small amounts of Notch ICD are required
to effectuate signaling (Karlstrom et al., 2002). Finally, we conﬁrmed
that the Notch1ΔETetOn cells expressed the ES stem cell markers Oct4,
Sox2, and SSEA-1, when cultured in the ES medium at the
undifferentiated state (Fig. 1G), and approximately 74% of the cells
were karyotypically normal (Supplementary Fig. 2C).
Activation of Notch at day 3 leads to increased Sox1 and CD133
mRNA expression
A protocol for robust induction of early neural differentiation in ES
cells has been developed, where ES cells are shifted from ES medium
containing LIF (Leukemia Inhibiting Factor) to N2B27 mediumll number after pulsed Notch activation at day 1, 2, 3, 4, 5, or 6 during neural induction.
s 1–6 of neural induction. (C) Analysis of activated caspase-3-positive cells after a day 3
ion proﬁle after a day 3 pulse, as compared to untreated cells. Analysis was performed at
, constant doxycycline treatment or in untreated cells, or after a combination of a day 3
n a bar graph in panel F. (G, H) Proportion of cells co-expressing nestin and BrdU after a
raph (H). (I) Schematic representation of the scheme for induction of endogenous Notch
h1ΔETetOn cells on immobilized ligand, as described in panel I. Samples were analyzed on
t had been cultured on Jagged1 or Fc ligand as indicated for 6 days during neural
r graphs show average activity from triplicates of each experiment, error bars indicate
*signiﬁcant difference at pb0.05. Scale bar: 40 μm.
Fig. 5. Blocking of PI3 kinase and MAP kinase abrogates Notch-induced proliferation and cyclin D1 and CDK6 expression. (A, B) Analysis of the BrdU-positive cell population in the
absence and presence of doxycycline pulse and with pharmacological inhibition of MAP kinase (U0126) and PI3 kinase signaling (Wortmannin). Wortmannin and U0126 were
added 30 min prior to Notch activation. The histogram (A) depicts the BrdU–APC population, and the bar graph (B) depicts the percentage of BrdU-positive cells. (C) Analysis of cell
cycle stages in the presence of U0126 andWortmannin alone or in combination. (D, E) Quantitative PCR analysis of cyclin D1 (D) and CDK6 (E) mRNA levels after Notch activation in
the presence or absence of U0126 and Wortmanin alone or in combination, as indicated. (F) Notch1ΔETetOn cells were transfected with dsRed alone or in combination with pCEP-
MEK* or pCG-p110* to activate MAP and PI3 kinase signaling, respectively. Notch signaling was then blocked with DAPT. The bar graph depicts BrdU labeling in cells with activated or
blocked Notch signaling in various combinations with activated Erk or PI3 kinase signaling, as indicated. Bar graphs show average activity from triplicates of each experiment, error
bars indicate standard deviation: ***signiﬁcant difference at pb0.001; **signiﬁcant difference at pb0.01; *signiﬁcant difference at pb0.05.
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monolayer culture (Stavridis and Smith, 2003). The Notch1ΔETetOn cells
didundergo the expecteddifferentiationwhen subjected to this protocol,
i.e., a progressive loss of Oct4 and a gain in nestin protein expressionwas
observed (Fig. 2A). At themRNA level, an increase in expression of Sox1,
BLBP, and nestin was noted during neural differentiation (Fig. 2B).
To explore temporal context dependency for Notch, we set up a
scheme where a 6 h doxycycline pulse was given at day 1, 2, 3, 4, or 5during the early neural differentiation, and the effects were analyzed
at day 6 (schematically summarized in Fig. 2C). In a parallel set of
experiments, the effects of constant exposure to doxycycline were
tested, and here cells were harvested and directly analyzed at each
day (0–4) during neural induction. As Sox1 is an early neural
progenitor marker, and upregulated in the earliest phase of neural
induction (Lowell et al., 2006), we deployed this inductive scheme to
learn whether Sox1 expression was altered upon temporal activation
161D. Das et al. / Developmental Biology 348 (2010) 153–166of Notch. The results revealed a signiﬁcant increase in the transcrip-
tion of Sox1 in cells pulsed with doxycycline on day 3, in comparison
to cells pulsed at other days, constantly exposed or not exposed at all
to doxycycline (Fig. 2D). Similarly, expression of CD133 (prominin 1),
which is expressed in neural progenitors (Peh et al., 2009), was
elevated by a day 3 pulse of Notch signaling, when analyzed on day 4
(Fig. 2E). The increase appeared to be transient, as analysis at a later
timepoint, day 9 during neural differentiation, did not yield a
signiﬁcant difference in expression of CD133 (data not shown).
Along with the increased amount of CD133 mRNA, an increase in the
Nestin–BrdU double-positive population was observed at day 4,
although the total number of nestin-positive cells did not increase at
day 4 (Fig. 2F). Upregulation of the proportion of nestin-expressing
cells was, however, observed when analyzed 14 days after neural
induction, following a day 3 pulse (Fig. 2G). Given the observed
increase in the Sox1 mRNA and CD133 protein levels, we were
interested if there were also effects on the choice between commit-
ments to the glial versus neuronal lineages, following a longer period
of differentiation. To address this, we cultured the Notch1ΔETetOn cells
as monolayer in neural differentiation medium with or without a
short pulse of doxycycline at day 3 for 6 additional days. Analysis of
Tuj1 (β-III-tubulin) and GFAP expression, as markers for early
neurons and astrocytes, respectively, revealed no signiﬁcant differ-
ence in the proportion of Tuj1- or GFAP-expressing cells between the
cultures exposed to a day 3 pulse of doxycycline versus no doxy-
cycline stimulation (Supplementary Fig. 3).
Activation of Notch at day 3 leads to increased proliferation
The elevation in Sox1 and CD133 expression speciﬁcally following
a day 3 doxycycline pulse spurred us to investigate whether pulsed
activation at day 3 may also affect cell number. A 6 h doxycycline
pulse was given to the cells at day 1, 2, 3, 4, or 5 and the total number
of cells was analyzed at day 6. The results showed that pulsing the
cells at day 3 led to a signiﬁcant upregulation in the number of cells at
day 6, as compared to pulsing the cells at the other days (Fig. 3A). We
next made a time course of the increase in cell number by analyzing
the total number of cells at each day during the 6 day neural induction
in two parallel cell cultures: one cultured in the absence of
doxycycline and the other pulsed for 6 h at day 3. There were, as
expected, no signiﬁcant difference in cell number at days 1–3 (i.e.,
before or at the doxycycline pulse), but starting at day 4, we noted a
small increase in cell number in the day-3-pulsed cells, which was
further augmented at days 5 and 6 (Fig. 3B).
The increase in cell number could be a result of a decrease in
apoptosis and/or an increase in the proliferative rate. We ﬁrst
analyzed apoptosis by staining for activated caspase-3, but no increase
in the proportion of cells expressing activated caspase-3 after the day
3 pulse, or after constant doxycycline stimulation, was observed
(Fig. 3C). Staurosporine-exposed cells were used as positive control
for measuring activated caspase-3 (data not shown). Moreover, the
expression of Bcl-2, an anti-apoptotic marker, was not signiﬁcantly
altered by the day 3 pulse (Fig. 3D). To study a possible change in
proliferation, we analyzed the incorporation of BrdU under the
different conditions. Cells subjected to constant doxycycline stimula-
tion, a day 3 pulse, or left untreated were supplemented with BrdU in
the culturing medium for 1 h at day 6, and the proportion of BrdU-
expressing cells was analyzed 1 h after the BrdU administration. In the
untreated cells and in the cells with constant doxycycline induction,
there were 43% and 46% BrdU-positive cells, respectively, and this was
signiﬁcantly increased in the day 3 pulse cells (56%) (Fig. 3E, F).
Blocking Notch signaling by DAPT in the day 3 pulse cells abrogated
the increase in the number of BrdU-positive cells, bringing it back
to 42% (Fig. 3F). To learn whether the increase in the proportion of
BrdU+ cells was conﬁned to a particular cell population, we deter-
mined the proportion of cells that were double-positive for BrdU andnestin, GFAP or Tuj1. The proportion of BrdU+/nestin+ cells was
signiﬁcantly increased in the day-3-pulsed cells (Fig. 3G, H). In
contrast, no signiﬁcant difference was observed for the BrdU+/GFAP+
cells or BrdU+/Tuj1+ cells (Supplementary Fig. 4). To corroborate the
ﬁnding that Notch induction by doxycycline stimulation enhanced
proliferation, we testedwhether activation of Notch signaling through
endogenous Notch receptors yielded a similar result. Endogenous
Notch signaling was activated by plating Notch1ΔETetOn cells that
were not doxycycline stimulated on immobilized recombinant
Jagged1 ligand on speciﬁc days during neural differentiation until
the day of analysis, to mimic as closely as possible the transient
induction by a doxycycline pulse (Fig. 3I). Ligand activation was
conﬁrmed by activation of Hey1 mRNA expression (Supplementary
Fig. 5), and ligand stimulation at day 3 during neural induction, but
not at the other days, led to an increase in the proportion of BrdU-
positive cells, as compared to cells cultured on only Fc fragment as
control (Fig. 3J). When the Notch1ΔETetOn cells were grown for 48 h
on Jagged1, mimicking constant Notch stimulation, no effect on
proliferation was observed (Fig. 3K). These data suggest that
activation of Notch signaling speciﬁcally at day 3 enhances cellular
proliferation.
Pulsed Notch activation at day 3 alters G1/S cell cycle control and
activates cyclin D1
The Notch-mediated increase in cell number and proliferationmay
be related to changes in cell cycle control. To explore in which phase
of the cell cycle Notch exerted its effect, day-3-pulsed or untreated
cells were labeled with propidium iodide and analyzed by FACS for
cell cycle phase distribution. The data revealed a slight increase in the
number of day-3-pulsed cells in S phase and a corresponding slight
decrease in the G0/G1 stage (Fig. 4A, B). This shift in the balance of S
phase versus G0/G1 phase was abrogated by the addition of DAPT
(Fig. 4A, B).
This indicated a modulation at the G1/S transition check point and
to explore how Notch impinges on the G1/S control, we searched for
changes in the expression of genes controlling various phases of the
cell cycle. Cyclins and Cyclin-dependent kinases (CDKs) are key cell
cycle regulators: cyclin D1 and CDK6 control the G1/S, cyclin A and
CDK2 control the G2 phase, whereas cyclin B and CDK1 control the M
phase check point. Analysis of mRNA expression levels revealed no
signiﬁcant changes for cyclin E, cyclin B1, cyclin A, CDK1, CDK2, and
CDK4 mRNAs (Supplementary Fig. 6), whereas, in contrast, cyclin D1
and CDK6 mRNAs were signiﬁcantly upregulated by the day 3 pulse,
as compared to untreated cells, when analyzed at 12 h post
doxycycline induction (Fig. 4C). Furthermore, when the combined
expression of cyclin D1 and CDK6 mRNAs was compared to the
combined expression of cyclin A and CDK2 or cyclin B and CDK1 in
day-3-pulsed and untreated cells, a signiﬁcant upregulation was
observed only for the cyclin D1 and CDK6 combination (Fig. 4D). In
keeping with the elevated mRNA expression, cyclin D1 was also
upregulated at the protein level (Fig. 4E). The altered G1/S transition
following a day 3 pulse was manifested also by an increase in
phosphorylated forms of the retinoblastoma protein (pRb 795 and
pRb 805/811) and a decrease in the cell cycle blockers p21 and p27
(Fig. 4E). The data suggested that the proliferative increase occurred
during the induction phase of neural differentiation, corresponding to
day 3, rather than at a more mature neural stem cell state,
corresponding to day 6. To explore the Notch–cyclin D1 relationship
in primary neural stem cells, we analyzed the effect of Notch
activation in cortical progenitor cells derived from embryonic day
(E) 15 rat embryos. The level of cyclin D1 mRNA expression was
increased after transfection of Notch1 ICD, and as expected, this
increase was not abrogated by DAPT (Supplementary Fig. 7A). As a
control, the level of Hes5 mRNA expression was also increased by
Notch1 ICD transfection (Supplementary Fig. 7B), and as expected
162 D. Das et al. / Developmental Biology 348 (2010) 153–166since Notch1 ICD was used, the upregulation could not be blocked by
addition of DAPT (Supplementary Figs. 7A,B). In conclusion, these data
point to an effect on the G1/S transition by Notch activation at day 3
during neural differentiation, linked with increased expression of
cyclin D1, and an ensuing increase of phosphorylated Rb protein.The Notch-mediated proliferative effect requires functional PI3 and MAP
kinase signaling
As Notch signaling extensively cross-talks with other signaling
pathways (for review, see Hurlbut et al., 2007; Lendahl et al., 2009;
163D. Das et al. / Developmental Biology 348 (2010) 153–166Poellinger and Lendahl, 2008), we wanted to learn whether the
increase in proliferation and gene expression by the day 3 pulse
required the activity of other signaling pathways. Blocking of the MAP
kinase pathway by the inhibitor Erk kinase inhibitor U0126 or
blocking PI3 kinase signaling by the inhibitor Wortmannin resulted in
an abrogation of the increase in the proportion of BrdU-positive cells
observed after the doxycycline pulse at day 3 (Fig. 5A, B). The increase
in the proportion of cells in S-phase, at the expense of cells in G2/M
phase, observed after Notch induction, was abrogated by treatment
with U0126 or Wortmannin alone or in combination, and blocking
MAP or PI3 kinase signaling in fact led to a further increase in G2/M
phase and a corresponding reduction of the number of cells in S phase
(Fig. 5C, Supplementary Fig. 8A). The elevation of cyclin D1 and CDK6
mRNA levels observed after Notch induction at day 3 were abrogated
by U0126 and Wortmannin treatment alone or in combination
(Fig. 5D, E). Finally, to address if activated MAP or PI3 kinase signaling
could substitute for activated Notch signaling in the induction of
proliferation, we treated the Notch1ΔETetOn cells with DAPT to block
Notch signaling and then activated Erk and PI3 kinase signaling by
transfecting pCEP-MEK* and pCG-p110*, which represent constitu-
tively active forms of Erk and PI3 kinase, respectively, along with
dsRED plasmid. DsRED-expressing cells were then sorted and
analyzed for BrdU incorporation. Expression of the constitutively
active forms of Erk and PI3 kinase (for control of expression levels of
pCEP-MEK* and pCG-p110*, and activity of pCEP-MEK*, see Supple-
mentary Fig. 8B, C) was not sufﬁcient to induce the increase in BrdU-
positive cells observed after Notch activation by doxycycline at day 3
(Fig. 5F). In sum, these data indicate that the Notch-mediated
proliferative effect requires MAP and PI3 kinase signaling but that
activatedMAP and PI3 kinase signaling cannot induce this effect in the
absence of Notch signaling.
Cyclin D1 is critically required for the Notch-mediated effect
on proliferation
To study whether the activation of cyclin D1 by Notch in the ES
cells involved regulation at the transcriptional level, we tested
whether a 1.7-kb cyclin D1 promoter element was responsive to
pulsed Notch activation during early neural induction. When the
Notch1ΔETetOn cells were given a 6-h doxycycline pulse at day 1, 2, 3,
4, or 5, we observed that the cyclin D1 promoter-luciferase reporter
construct (Leslie et al., 2006) was signiﬁcantly upregulated only by a
pulse at day 3 (Fig. 6A). The enhanced activation of the cyclin D1
promoter at day 3 led us to analyze whether day 3 represented a
unique stage also with regard to endogenous Notch activation and
cyclin D1 expression. We tested this by transfecting in the Notch
reporter construct 12XCSL-luc or a cyclin D1-luciferase reporter
construct at different days of neural differentiation and then recorded
the reporter gene activity in untreated cells, i.e., under endogenous
Notch signaling conditions, at 24 h post-transfection. In both cases,
there was an increase in reporter gene activity up to days 3 and 4
(Fig. 6B, C, Supplementary Fig. 9). Both the Notch-induced cyclin D1-
luc and 12XCSL-luc activation could be blocked by DAPT (Fig. 6D).
Together, these data suggest that there is a peak of endogenous NotchFig. 6. Cyclin D1 is required for the Notch-mediated effect on proliferation. Activation of a cyc
indicated. (B) Activation of the 12XCSL-luciferase reporter under endogenous Notch condit
Analysis in panels A–C was carried out 24 h post-transfection. (D) Activation levels of 1
(E) Analysis of the effects of dominant negative (dn-T156A) or constitutively active (caT286
was transfected alone (two leftmost lanes) or in combination with dn-T156A/caT286A to
statistical signiﬁcance was calculated with respect to the BrdU positive population in PulDo
pulsed (PulDox) cells. Analysis was performed on day 4 during neural induction, and cells p
intracellular localization of cyclin D1 in response to pulsed Notch activation and analyzed o
expressing cyclin D1, whereas arrowheads denote DAPI-stained nuclei expressing cyclin D1
(PulDox) cells as analyzed on day 4 during neural induction. (I)Western blot analysis of cycli
3 antibody as control for nuclear fractionation. Below, comparison of the amount of nuclear
internal control. Analysis was carried out at day 4 during neural induction. Bar graphs sh
deviation: ***signiﬁcant difference at pb0.001; **signiﬁcant difference at pb0.01; *signiﬁcaactivity at day 3, a stage which also exhibits enhanced cyclin D1
promoter activity.
The effect on cell proliferation and the direct upregulation of cyclin
D1 by doxycycline stimulation suggests, but does not directly prove,
that cyclin D1 is the “culprit” of Notch activation resulting in increased
cell proliferation. To address this issue, we tested whether expression
of a dominant-negative version of cyclin D1 (cyclin D1-T156A) could
override the Notch-induced cell proliferation. When Notch1ΔETetOn
cells were transfected with the cyclin D1-T156A construct at day 2
(and co-transfected with dsRED to allow for FACS sorting for
expressing cells followed by a doxycycline pulse at day 3, and analysis
at day 6), we noted a signiﬁcant reduction in the proportion of BrdU-
positive cells, as compared to cells that were pulsed and only dsRED-
transfected and FACS sorted (Fig. 6E). The percentage of BrdU-positive
cells was reduced by cyclin DN-T156A to a level below the dsRED-
only-transfected cells (Fig. 6E; for transfection efﬁciency, see
Supplementary Fig. 10), suggesting that endogenous cyclin D1
function was also reduced, resulting in a further reduction in cell
proliferation. Conversely, transfection of a constitutively active form
of cyclin D1, cyclinD1-T286A, increased cell proliferation to a similar
extent both in the untreated and in the day-3-pulsed cells (Fig. 6E, for
transfection efﬁciency see Supplementary Fig. 10), indicating that
elevated expression of cyclin D1 can substitute for Notch activation.
Cyclin D1 can be localized both to the nucleus and the cytoplasm,
and an altered nuclear versus cytoplasmic ratio has been reported in
response to different stimuli (Alt et al., 2000). We were therefore
curious to learn whether the upregulation of cyclin D1 expression by
the brief activation of Notch at day 3 affected the intracellular
distribution of cyclin D1. Cells subjected to a 6-h doxycycline pulse
showed a more prominent nuclear distribution, as compared to non-
induced cells, i.e., 91% of the day-3-pulsed cells exhibited a nuclear
expression, versus 67% of the non-induced cells (Fig. 6F, G). FACS
analysis of cyclin-D1-positive cell nuclei revealed a similar increase in
the proportion of cyclin-D1-positive nuclei: 50% versus 38% for pulsed
and non-induced cells, respectively (Fig. 6H). The increase in nuclear
localization of cyclin D1 observed in Fig. 6F–H was paralleled with an
increase in the amount of cyclin D1 in the nucleus after the day 3
doxycycline pulse, as judged by Western blot analysis (Fig. 6I). In
conclusion, these data reveal that Notch controls cyclin D1 expression
and that cyclin D1 is a critical mediator of the Notch-induced effect on
proliferation.
Reduced cyclin D1 expression in mice with defective Notch signaling
To address whether the level of cyclin D1 expression was
controlled by Notch expression also in the developing CNS in vivo,
we compared the distribution of cyclin D1 in the developing spinal
cord of E10.5 wild-type and JaggedNdr/Ndr mouse embryos (Fig. 7A–F).
JaggedNdr/Ndr mice carry a missense mutation in the Jagged1 ligand,
which renders the Jagged1 ligand signaling incompetent (Hansson
et al., 2010). Cyclin D1 expression was predominantly conﬁned to a
speciﬁc dorsoventral domain, the dp6 domain, and with considerably
lower expression in the ﬂanking p0 and p2 domains in the E10.5
embryo (Fig. 7B, C). The dp6 domain also exhibited high levels oflin D1-luciferase reporter construct after pulsed activation of Notch at day 1, 2, 3, or 4, as
ions. (C) Analysis of cyclin D1-luciferase reporter under endogenous Notch conditions.
2XCSL-luciferase and cyclin D1-luciferase reporters in response to DAPT treatment.
A) cyclin D1 forms on the Notch-induced increase in proliferation. The dsRED plasmid
allow for FACS sorting of transfected cells. The samples were analyzed on day 6. The
x cells. (F) The proportion of cells with nuclear cyclin D1 in control (−Dox) and day-3-
ositive for cyclin D1 were counted under the microscope. (G) Immunocytochemistry of
n day 3 post activation of Notch signaling. Arrows denote DAPI-stained cell nuclei not
. (H) Proportion of cyclin D1-positive cell nuclei in control (−Dox) and day-3-pulsed
n D1 content in the cytoplasmic (Cy) and nuclear (Nu) fractions. Reprobing with Histone
cyclin D1 in uninduced and day-3-pulsed cells. Reprobing with Histone 3 antibody as
ow average activity from triplicates of each experiment, error bars indicate standard
nt difference at pb0.05. Scale bar=20 μm.
Fig. 7. Absence of Notch signaling decreases expression of cyclin D1. (A) Schematic representation of the embryonic spinal cord, where the area shown in panels B and D is indicated
(rectangle). The various dorsoventral progenitor domains at the ventral side of the spinal cord are denoted (FP= ﬂoor plate) and the dp6 domain expresses Jagged1 (data not shown
and Lindsell et al., 1996; Mitsiadis et al., 1997). Panel B represents a section from an E10.5 wild-type embryo (10× magniﬁcation in panel C), whereas panel D represents a section
from a (Jagged1Ndr/Ndr (Nodder)) littermate embryo (10×magniﬁcation in panel E). The sections are stained for cyclin D1 (red) and DAPI (blue). (F) Average of the quantiﬁed results
for nuclear cyclin D1 expression in both wild-type and Jagged1Ndr/Ndr littermate mouse embryos derived from three different litters. (G–H) Neural tube section of E8.5 wild-type and
CSL-/- mice. Sections stained with cyclin D1 (red) and DAPI (blue). Scale bars: (B, D=50 μm; C, E=5 μm; G, H, I, M, N, O=50 μm; J, K, L, P, Q, R=20 μm.
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studies (Lindsell et al., 1996; Marklund et al., 2010). A reduced level
of cyclin D1 expression in the JaggedNdr/Ndr embryo was observed
(Fig. 7D, E), as compared to the wild-type littermate embryo (Fig. 7B,
C). Furthermore, the proportion of cells with nuclear cyclin D1
expression was higher in the wild-type mice (Fig. 7C), as compared
with the JaggedNdr/Ndr embryos (Fig. 7E; quantiﬁed in Fig. 7F). To
corroborate the ﬁndings from the JaggedNdr/Ndr embryos, we analyzed
cyclin D1 distribution in mice deﬁcient for CSL. CSL−/− E8.5 mouse
embryos showed a signiﬁcantly reduced cyclin D1 immunostaining in
the corresponding region of the developing neural tube (Fig. 7G–R).Discussion
Signaling mechanisms controlling cell fate decisions at multiple
stages in a cell lineagemust be able to interpret a temporally changing
cellular context and integrate this information to generate a signaling
output appropriate for each particular temporal stage in the cell
lineage. In this report, we provide evidence that activation of the
Notch pathway at different stages of early neural differentiation in
mouse ES cells produces a stage-speciﬁc output: a brief activation at
day 3 during neural differentiation leads to an increase in cell numberand elevated expression of cyclin D1, and cyclin D1 is critically
required for the observed increase in cell number.
The increase in cell number following a day 3 pulse is likely caused
by enhanced proliferation, as BrdU incorporation was elevated, but
without a signiﬁcant reduction in apoptosis. The increase in cell
number was accompanied by a shift in cell cycle phase distribution,
with a small increase in the proportion of cells in S phase and a
corresponding decrease of the number of cells in the G1 phase.
Analysis of the key cell cycle components revealed a promotion of the
G1/S transition, as the levels of cyclin D1 and CDK6, but not of other
cyclins or CDK proteins, were elevated. The fact that the level of cyclin
D1 mRNA was upregulated, and that a 1.7-kb cyclin D1 promoter was
responsive to activation of Notch, suggests that cyclin D1 is a direct
Notch target gene in mouse ES cells. The Notch-mediated increase in
cellular proliferation and cyclin D1 and CDK6 expression required
functional MAP and PI3 kinase signaling, as pharmacological inter-
vention with these two pathways abrogated the Notch-mediated
effect. Notch activation was, however, required, as no increase in
proliferation or cyclin D1 and CDK6 expression was observed when
MAP and PI3 kinase signaling was activated under conditions of
blocked Notch signaling.
Our data indicate that the Notch-induced increase in cyclin D1
levels is critical for the observed increase in cell proliferation. Firstly,
165D. Das et al. / Developmental Biology 348 (2010) 153–166the enhanced level of cyclin D1 was accompanied by elevated
phosphorylation of the Rb protein and decreased levels of the two
cell cycle inhibitors p21 and p27. Secondly, expression of a dominant
negative cyclin D1 abrogated the increase in proliferation observed
after Notch activation at day 3. Thirdly, expression of a constitutively
active form of cyclin D1 was, in the absence of Notch activation,
sufﬁcient to mediate a proliferative effect similar to that observed
after the brief Notch activation. Collectively, this argues that the
Notch-mediated effect proceeds through activation of cyclin D1. The
notion that Notch regulates cyclin D1 expression in early neural
differentiation receives support also by the observation that cyclin D1
immunoreactivity was reduced in areas of active Notch signaling in
the developing CNS in two mouse models deﬁcient for functional
Notch signaling. The ﬁnding that cyclin D1 is a downstream target
gene of Notch is in keeping with previous observations from other cell
types, such as tumor cells (Ronchini and Capobianco, 2001) and
cardiomyocytes (Campa et al., 2008). The identiﬁcation of cyclin D1 as
the critical Notch downstream mediator of proliferation furthermore
extends a recent ﬁnding on expression of cyclin D1 in early cortical
differentiation in the mouse, where elevated cyclin D1 levels
promoted generation and expansion of the CNS progenitor cell pool
(Lange et al., 2009).
The data presented here not only provide evidence for a Notch-
induced increase in cyclin D1 expression and cell proliferation but also
identify day 3 in neural differentiation of ES cells as a temporal state
endowed with special properties. In addition to the speciﬁc Notch
response, day 3 is also characterized by a strong increase in Sox1
expression, and upregulation of the neural markers nestin and BLBP.
We, however, cannot yet tell whether the speciﬁc upregulation of cyclin
D1byNotchatday3 is a consequence ofNotch signalingbecomingmore
effective, upregulating a broader repertoire of genes, or whether the
cyclin D1 gene speciﬁcally becomes more susceptible to upregulation.
The fact that the 12XCSL-reporter activation was elevated at day 3 also
under endogenous Notch signaling conditions may support the notion
that this stage is generally more sensitized to Notch signaling, but to
understand this will require further analysis of the global Notch
signaling output and the chromatin state of the cyclin D1 promoter.
We found that Notch enhanced the proportion of neural
progenitors, deﬁned by expression of nestin, BLBP and CD133, but
did not signiﬁcantly affect the ratio between GFAP- and β-III-tubulin-
expressing cells, as markers for astrocytes and early neurons,
respectively. This suggests that in the window of early neural
differentiation that we study, there is an enhanced generation of
progenitor cells rather than a shift in the proportion between
neuronal and glial fates. This notion is further supported by the fact
that the majority of the BrdU-positive cells were also nestin-positive.
This ﬁnding is in keeping with a previous report, which showed that
constitutive expression of Notch1 ICD in mouse ES cells led to
accelerated entry into the neural lineage when ES cells were shifted
from ES to N2B27 medium (Lowell et al., 2006).
In conclusion, the data presented here provide insights into a
temporal context-dependent output of Notch signaling and identify a
temporal window in early neural differentiation of ES cells, in which
the cells are susceptible to a Notch-induced, cyclin-D1-dependent
increase in proliferation. This may pave the way for a better
understanding both of the diversity in the Notch signaling output
and of the temporally shifting cell context during early ES cell neural
differentiation.
Supplementarymaterials related to this article can be found online
at doi:10.1016/j.ydbio.2010.09.018.
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